Aspirin as an Adjuvant Therapy

Grant Details

Grantee Name:
 Prof. Toh Han Chong
Organization: National Cancer Centre Singapore

Country: Singapore

Project Name: ASCOLT STUDY (phase III): Aspirin as an Adjuvant Therapy for Colorectal Cancer

Funding Year: 2016

Project period: 5 years

ASCOLT STUDY (phase III): Aspirin as an Adjuvant Therapy for Colorectal Cancer

This phase III trial will assess the effectiveness of daily aspirin against placebo control in stage 2 and 3 patients. This is an international collaboration led by researchers in Singapore, UK, and Australia, and involves 50 sites in 11 countries across Asia.

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.